Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures

Tarlo, S.M.; Liss, G.M.; Yeung, K.S.
January 2002
Occupational & Environmental Medicine;Jan2002, Vol. 59 Issue 1, p58
Academic Journal
Presents information on a study which assessed changes in incidence and severity of compensated claims for occupational asthma due to diisocyanates compared with other causes, which have occurred since the introduction of a medical surveillance program in Ontario. Methods; Results; Discussion.


Related Articles

  • Benefits claims for industrial injury. Watkins, Jean // GP: General Practitioner;12/7/2007, p34 

    The article presents information on the industrial diseases and disorders for which medical benefits are available in Great Britain. As stated, benefits for cataract problems are available for those employed in Great Britain only. Workers with tenosynovitis are also liable for claims. As stated,...

  • Costs of occupational asthma in the UK. Jon G Ayres // Thorax;Feb2011, Vol. 66 Issue 2, p128 

    OBJECTIVES: To estimate the social costs of occupational asthma in the UK. METHODS: A desk-top approach using cost-of-illness methodology was employed, defining direct and indirect lifetime costs for six scenarios: a male and a female worker each exposed to isocyanates, latex and biocides (eg,...

  • International Research & Opinion.  // PharmacoEconomics & Outcomes News;4/4/2009, Issue 575, p7 

    This section discusses several therapeutics-related studies. An analysis revealed that the choice of inhaled corticosteroid may affect overall asthma control under actual living conditions. A study evaluated insurance claims for people with employer-sponsored health insurance which incorporated...

  • Checklist helps employers evaluate asthma and allergy benefits. Chipps, Bradley // Employee Benefit News;Sep2006, Vol. 20 Issue 11, p43 

    The article outlines the significant components of the checklist developed by the American College of Allergy, Asthma and Immunology for employers who want to offer high-quality care to their employees suffering from allergies or asthma. The importance of an unrestricted access to a specialist...

  • Better adherence, lower healthcare costs for diabetes patients enrolled in value-based insurance designs. Ehrlich, Emily // Formulary;Oct2013, Vol. 48 Issue 10, p341 

    The article presents information on value-based insurance designs (VBID) program to fight against diseases like diabetes, and asthma in the U.S. Tables containing details of the drug adherence and utilization under VBID program are also given, which reflect on the impact of such programs on the...

  • Host factors in occupational diisocyanate asthma: a Swiss longitudinal study. Berode, M.; Jost, M.; Ruegger, M.; Savolainen, H. // International Archives of Occupational & Environmental Health;Mar2005, Vol. 78 Issue 2, p158 

    Objective:To investigate the usefulness of surrogates for individual susceptibility to organic diisocyanates in occupational asthma.Subjects:All new cases declared to the Swiss National Accident Insurance Company (SUVA) for establishment of a case for compensable occupational disease during...

  • Diisocyanates and Nonoccupational Disease: A Review. Krone, Cheryl A. // Archives of Environmental Health;Jun2004, Vol. 59 Issue 6, p306 

    The article presents information on diisocyanates, one of the most common cause of occupational asthma. Diisocyanates produces respiratory disorders even at low exposures. Dermal contact can also provoke dermatitis, with symptoms such as rash, itching, hives and swelling of the extremities. More...

  • Medical surveillance programme for diisocyanate exposure. Labrecque, Manon; Malo, Jean-Luc; Alaoui, Khadija M.; Rabhi, Khalil // Occupational & Environmental Medicine;Apr2011, Vol. 68 Issue 4, p302 

    Objectives Surveillance programmes for occupational asthma should reduce the severity of asthma both at the time of diagnosis and after removal from exposure as well as costs related to functional impairment. The aim of this study was to compare the severity and cost of diisocyanate-induced...

  • Per-Employee Health Costs Jump 6.9 Percent. Miller, Stephen // HR Magazine;Jan2011, Vol. 56 Issue 1, p14 

    The article reports on the 6.9 percent increase in the average total health benefit cost per employee in the U.S. in 2010, according to the 2010 National Survey of Employer-Sponsored Health Plans by consulting firm Mercer.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics